Treatment Indications: correction of moderate to deep wrinkles and facial folds (nasolabial folds, marionette lines, bunny lines);, restoration of facial volume and contours (cheeks, cheekbones, chin, jawline, temples, forehead);, addressing age-related volume loss; biostimulation of neocollagenesis for sustained skin rejuvenation
Release form: 2 × 1 mL pre-filled sterile syringes
Compound: 30% polycaprolactone (PCL) microspheres (25–50 μm, smooth spherical particles, non-animal origin) suspended in 70% carboxymethylcellulose (CMC) gel carrier
Concentration of GC: not applicable (PCL-based filler, not hyaluronic acid); PCL microspheres — 30%
Lidocaine: No
Indications: injection into deep dermis, subcutaneous layer, or supraperiosteally;, dual-action mechanism — immediate volumizing effect from CMC gel carrier followed by gradual stimulation of collagen type I production as PCL microspheres act as a scaffold;, CMC carrier resorbed within 2–3 months and replaced by new collagen; effect duration approximately 24 months